Effects of neonatal MK-801 treatment on p70S6K-S6/eIF4B signal pathways and protein translation in the frontal cortex of the developing rat brain - PubMed (original) (raw)
. 2010 Oct;13(9):1233-46.
doi: 10.1017/S1461145709991192. Epub 2010 Jan 11.
Affiliations
- PMID: 20064280
- DOI: 10.1017/S1461145709991192
Free article
Effects of neonatal MK-801 treatment on p70S6K-S6/eIF4B signal pathways and protein translation in the frontal cortex of the developing rat brain
Se Hyun Kim et al. Int J Neuropsychopharmacol. 2010 Oct.
Free article
Abstract
Systemic injections of MK-801, a selective NMDAR antagonist, into neonatal rats induces long-term neurochemical and behavioural changes. It has been suggested that these changes form the neurodevelopmental basis for schizophrenia-like behaviour in rats. In this study, 7-d-old rats were treated with MK-801, and their frontal cortices were examined to investigate the effects on p70S6K-S6 signal pathway and on protein translation, which play crucial roles in the neurodevelopmental process. MK-801, in doses of 0.5 and 1.0 mg/kg, induced a decrease in phosphorylation of p70S6K and its substrates, S6 and eIF4B, in the first 8 h, and no change at 24 and 48 h. These effects were more prominent after two injections of MK-801 than one. Decreased S6 phosphorylation by MK-801 was evident in the prefrontal, cingulate, and insular cortex. In two representative upstream p70S6K-S6 pathways related to ERK1/2 and Akt, changes in ERK1/2-p90RSK phosphorylation were accompanied by changes of p70S6K-S6. Although two MK-801 injections induced a dose-dependent decrease in phosphorylation of Akt and mTOR at 4 and 8 h, a single injection did not produce a significant effect. Protein synthesis rate, measured by [3H]leucine incorporation in frontal cortical tissue, was reduced until 24 h after two MK-801 (1.0 mg/kg) injections. In summary, this study found that neonatal MK-801 treatment induced dysregulation in the p70S6K-S6/eIF4B pathway and protein translation in the frontal cortex of the developing rat brain, which may suggest an important role of protein translation machinery in the MK-801 neurodevelopmental animal model of schizophrenia.
Similar articles
- Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates mTOR signal pathways and protein translation in the rat frontal cortex.
Kim SH, Yu HS, Park HG, Ha K, Kim YS, Shin SY, Ahn YM. Kim SH, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:73-82. doi: 10.1016/j.pnpbp.2013.04.018. Epub 2013 May 2. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23643758 - The effect of MK-801 on mTOR/p70S6K and translation-related proteins in rat frontal cortex.
Yoon SC, Seo MS, Kim SH, Jeon WJ, Ahn YM, Kang UG, Kim YS. Yoon SC, et al. Neurosci Lett. 2008 Mar 21;434(1):23-8. doi: 10.1016/j.neulet.2008.01.020. Epub 2008 Jan 16. Neurosci Lett. 2008. PMID: 18262357 - Reduction in the protein level of c-Jun and phosphorylation of Ser73-c-Jun in rat frontal cortex after repeated MK-801 treatment.
Ahn YM, Seo MS, Kim SH, Jeon WJ, Kim Y, Kang UG, Juhnn YS, Kim YS. Ahn YM, et al. Psychiatry Res. 2009 May 15;167(1-2):80-7. doi: 10.1016/j.psychres.2007.12.013. Epub 2009 Apr 1. Psychiatry Res. 2009. PMID: 19342105 - The effects of MK-801 on the phosphorylation of Ser338-c-Raf-MEK-ERK pathway in the rat frontal cortex.
Ahn YM, Seo MS, Kim SH, Kim Y, Juhnn YS, Kim YS. Ahn YM, et al. Int J Neuropsychopharmacol. 2006 Aug;9(4):451-6. doi: 10.1017/S1461145705005882. Epub 2005 Aug 4. Int J Neuropsychopharmacol. 2006. PMID: 16079022 - Cellular function of p70S6K: a role in regulating cell motility.
Berven LA, Crouch MF. Berven LA, et al. Immunol Cell Biol. 2000 Aug;78(4):447-51. doi: 10.1046/j.1440-1711.2000.00928.x. Immunol Cell Biol. 2000. PMID: 10947872 Review.
Cited by
- Behavioral and transcriptional effects of repeated electroconvulsive seizures in the neonatal MK-801-treated rat model of schizophrenia.
Lee J, Huh S, Park K, Kang N, Yu HS, Park HG, Kim YS, Kang UG, Won S, Kim SH. Lee J, et al. Psychopharmacology (Berl). 2024 Apr;241(4):817-832. doi: 10.1007/s00213-023-06511-7. Epub 2023 Dec 11. Psychopharmacology (Berl). 2024. PMID: 38081977 - Functionally distinct roles for eEF2K in the control of ribosome availability and p-body abundance.
Smith PR, Loerch S, Kunder N, Stanowick AD, Lou TF, Campbell ZT. Smith PR, et al. Nat Commun. 2021 Nov 23;12(1):6789. doi: 10.1038/s41467-021-27160-4. Nat Commun. 2021. PMID: 34815424 Free PMC article. - Transcriptomics Analysis Reveals Shared Pathways in Peripheral Blood Mononuclear Cells and Brain Tissues of Patients With Schizophrenia.
Song X, Liu Y, Pu J, Gui S, Zhong X, Chen X, Chen W, Chen X, Chen Y, Wang H, Cheng K, Zhao L, Xie P. Song X, et al. Front Psychiatry. 2021 Sep 22;12:716722. doi: 10.3389/fpsyt.2021.716722. eCollection 2021. Front Psychiatry. 2021. PMID: 34630179 Free PMC article. - Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia.
Ibarra-Lecue I, Diez-Alarcia R, Morentin B, Meana JJ, Callado LF, Urigüen L. Ibarra-Lecue I, et al. Front Pharmacol. 2020 Mar 24;11:344. doi: 10.3389/fphar.2020.00344. eCollection 2020. Front Pharmacol. 2020. PMID: 32265715 Free PMC article. - The protective effects of Mogroside V and its metabolite 11-oxo-mogrol of intestinal microbiota against MK801-induced neuronal damages.
Ju P, Ding W, Chen J, Cheng Y, Yang B, Huang L, Zhou Q, Zhu C, Li X, Wang M, Chen J. Ju P, et al. Psychopharmacology (Berl). 2020 Apr;237(4):1011-1026. doi: 10.1007/s00213-019-05431-9. Epub 2020 Jan 3. Psychopharmacology (Berl). 2020. PMID: 31900523
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous